CTC Capital Management’s Repligen RGEN Stock Holding History

CTC Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,600	Closed	-$486K	–	166
2022 Q3	$486K	Buy	+2,600	New	+$548K	0.39%	60

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CTC Capital Management's RGEN Position: Q4 2022 in Review

CTC Capital Management sold out of Repligen (RGEN) in Q4 2022, closing a stake of 2,600 shares — an estimated $486K sold.

CTC Capital Management first reported a position in RGEN in Q3 2022 and held it in 1 quarter. The position peaked at $486K in Q3 2022. 442 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.

CTC Capital Management reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
CTC Capital Management sold 2,600 Repligen shares in Q4 2022, an estimated $486K.
CTC Capital Management first reported a position in Repligen in Q3 2022 and held it in 1 quarter.
CTC Capital Management's Repligen position peaked at $486K in Q3 2022.
442 funds tracked by Wall St. Rank held Repligen as of Q4 2022.

Based on CTC Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.